发明授权
US08008037B2 Matrix composition with alkylphenazine quaternary salt and a nitrosoaniline
有权
具有烷基吩嗪季盐和亚硝基苯胺的基质组成
- 专利标题: Matrix composition with alkylphenazine quaternary salt and a nitrosoaniline
- 专利标题(中): 具有烷基吩嗪季盐和亚硝基苯胺的基质组成
-
申请号: US12056473申请日: 2008-03-27
-
公开(公告)号: US08008037B2公开(公告)日: 2011-08-30
- 发明人: Christopher D. Wilsey , Mitali Ghoshal , Herbert Wieder
- 申请人: Christopher D. Wilsey , Mitali Ghoshal , Herbert Wieder
- 申请人地址: US IN Indianapolis
- 专利权人: Roche Diagnostics Operations, Inc.
- 当前专利权人: Roche Diagnostics Operations, Inc.
- 当前专利权人地址: US IN Indianapolis
- 代理机构: Woodard, Emhardt, Moriarty, McNett & Henry LLP
- 主分类号: C12Q1/32
- IPC分类号: C12Q1/32
摘要:
A chemistry matrix for use in determining the concentration of an analyte in a biological fluid includes a glucose dehydrogenase, nicotinamide adenine dinucleotide, an alkylphenazine quaternary salt, and/or a nitrosoaniline. The chemistry matrix is used with an electrochemical biosensor to determine the concentration of an analyte after a reaction occurs within the biosensor, at which time an analysis is completed to determine the concentration. A method of determining the concentration of an analyte using the chemistry matrix of glucose dehydrogenase, nicotinamide adenine dinucleotide, an alkylphenazine quaternary salt, and/or a nitrosoaniline is another aspect that is described. The method also further features test times of five seconds or less. Methods utilizing the new chemistry matrix can readily determine an analyte such as blood glucose at concentrations of from about 20-600 mg/dL at a pH of from about 6.5 to about 8.5.
公开/授权文献
- US20090246808A1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY 公开/授权日:2009-10-01
信息查询